Jovan Antovic
Overview
Explore the profile of Jovan Antovic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
260
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kimiaei A, Pruner I, Farm M, Holmstrom M, Karandyszowska N, Bruzelius M, et al.
Haemophilia
. 2025 Mar;
PMID: 40052420
Background: Von Willebrand disease (vWD) is a common bleeding disorder with different subtypes. Laboratory diagnosis is challenging, involving several expensive and complex assays. The von Willebrand factor (vWF) collagen binding...
2.
Almskog L, Sjostrom A, Sunden-Cullberg J, Taxiarchis A, Agren A, Freyland S, et al.
Thromb Res
. 2024 Sep;
243():109135.
PMID: 39226747
Background: Despite medical interventions, COVID-19 continues to persist at pandemic proportions. A hypercoagulation state was rapidly observed in the severely ill, and the incidence of thromboembolic events remains elevated. Interleukin...
3.
Dumitrescu G, Antovic J, Soutari N, Gran C, Antovic A, Al-Abani K, et al.
PLoS One
. 2024 Aug;
19(8):e0309112.
PMID: 39178205
Complement and extracellular vesicles (EVs) association with thrombogenic tendencies is acknowledged, but limited evidence exists for their link to COVID-19 venous thromboembolism. This study aims to examine the relationship between...
4.
Iglesias M, Sanchez-Rivera L, Ibrahim-Kosta M, Naudin C, Munsch G, Goumidi L, et al.
Nat Commun
. 2023 Nov;
14(1):7752.
PMID: 38012230
No abstract available.
5.
Dunjic Manevski S, Cumbo M, Pruner I, Gvozdenov M, Tomic B, Taxiarchis A, et al.
Int J Lab Hematol
. 2023 Nov;
46(2):329-335.
PMID: 37918971
Introduction: Prothrombin Belgrade mutation is the result of the c.1787G>A substitution in the prothrombin gene. It is located in the antithrombin and sodium binding site and leads to impaired inactivation...
6.
Taxiarchis A, Bellander B, Antovic J, Soutari N, Virhammar J, Kumlien E, et al.
Int J Lab Hematol
. 2023 Oct;
46(1):42-49.
PMID: 37795549
Introduction: Increased levels of extracellular vesicles (EVs) are associated with haemostatic disturbances in various clinical settings. However, their role in COVID-19 patients is still not fully clear. In the present...
7.
Schmidt D, Truedsson A, Stralfors A, Hojbjerg J, Soutari N, Holmstrom M, et al.
Thromb Haemost
. 2023 Jul;
124(1):32-39.
PMID: 37494968
Background: Discrepancy in factor IX activity (FIX:C) between one-stage assay (OSA) and chromogenic substrate assay (CSA) in patients with hemophilia B (PwHB) introduces challenges for clinical management. Aim: To study...
8.
Iglesias M, Sanchez-Rivera L, Ibrahim-Kosta M, Naudin C, Munsch G, Goumidi L, et al.
Nat Commun
. 2023 Jun;
14(1):3280.
PMID: 37286573
Venous thromboembolism (VTE) is a common, multi-causal disease with potentially serious short- and long-term complications. In clinical practice, there is a need for improved plasma biomarker-based tools for VTE diagnosis...
9.
Bian L, Baghaei F, Antovic J, Fagerberg Blixter I, Hillarp A, Strandberg K, et al.
Lakartidningen
. 2022 Jun;
119.
PMID: 35713306
Activated partial thromboplastin time (APTT) is widely practiced in preoperative screening. The value of using this test to predict the risk of perioperative bleeding is not well documented in Sweden....
10.
von Horn H, Rasmusson A, Soderblom L, Malmstrom R, Antovic J
Int J Lab Hematol
. 2021 Sep;
44(1):163-167.
PMID: 34523813
Introduction: Direct oral anticoagulant (DOAC)-inhibiting factor Xa (FXa-DOAC) are being increasingly used as prophylaxis of venous thromboembolism and for prevention of stroke in patients with atrial fibrillation. In contrast to...